BioSpace

Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing

The BioSpace 40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI-driven analytics and Ohio’s gene therapy ecosystem—with a responsibility to patients worldwide.

By BioSpace

1 min read
Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights